AGX840

Recombinant SARS-CoV-2 Nucleocapsid Protein (whole length)

suitable for ELISA

• Sinônimo(s): 2019-nCoV, SARS-CoV
• Código UNSPSC: 51201600

Propriedades

• recombinante: expressed in E. coli
• Nível de qualidade: 100
• forma: liquid
• condição de armazenamento: avoid repeated freeze/thaw cycles
• técnica(s): ELISA: suitable
• Condições de expedição: dry ice

Descrição

Descrição geral

This e. coli recombinant SARS-CoV-2 Nucleocapsid Protein (whole length), Cat. No. AGX840 is tested for use in ELISA.

Especificidade

SARS CoV2

Descrição-alvo

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

forma física

Purified recombinant protein in 0.01M PBS, pH7.4

Reconstituição

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Armazenamento e estabilidade

Stable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.

Exoneração de responsabilidade

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Informações de segurança

• Código de classe de armazenamento: 12 - Non Combustible Liquids
• Classe de risco de água (WGK): WGK 2
• Ponto de fulgor (°F): Not applicable
• Ponto de fulgor (°C): Not applicable